跳至主要内容
临床试验/IRCT2014070512765N4
IRCT2014070512765N4已完成3 期

Clinical trial in evaluation of the efficacy of defroxamine-deferiprone on cardiac function in patients with major thalassemia

Golestan University of Medical Sciences0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 years 至 no limit(—)
性别
All

入选标准

  • Patients were treated with iron chelators Subcutaneous Deferoxamine with a doseof 30-50 mg/kg for 5 nights a week for 3 years before starting the study. Exclusion criteria: gastrointestinal complications; failure to cooperate in the control tests (ALT, CBC); becoming tired of the traffic for controlling consumption of deferiprone

排除标准

  • 未提供

研究者

发起方
Golestan University of Medical Sciences

相似试验